Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients

ClinicalTrials.gov ID: NCT00002410

Public ClinicalTrials.gov record NCT00002410. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Open-Label Study to Compare Antiretroviral Activity and Tolerability of Three Different Combination Regimens (DMP 266 + Indinavir, DMP 266 + Zidovudine + Lamivudine, Indinavir + Zidovudine + Lamivudine) in HIV-Infected Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and effectiveness of three anti-HIV drug combinations. The three combinations are: (1) efavirenz (DMP 266) plus indinavir; (2) DMP 266 plus zidovudine (ZDV) plus lamivudine (3TC); and (3) indinavir plus ZDV plus 3TC. This study also examines the resistance HIV may have to these drugs and if these drugs are effective over a long period of time.

Study identification

NCT ID
NCT00002410
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Dupont Merck
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
13 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
33
Facility City State ZIP Site status
Phoenix Body Positive Phoenix Arizona 85016 —
Arizona Clinical Research Ctr Inc Tucson Arizona 85712 —
Richard Stryker Beverly Hills California 90210 —
Paul Cimoch Irvine California 92618 —
AIDS Healthcare Foundation Los Angeles California 90027 —
Kraus Med Group Los Angeles California 90036 —
Oasis Clinic / Martin Luther Jr Gen Hosp / King-Drew Med Ctr Los Angeles California 90059 —
Blick Med Associates Stamford Connecticut 06901 —
Novum Inc Washington D.C. District of Columbia 20037 —
Bach and Godofsky Bradenton Florida 34205 —
Community Research Initiative of South Florida Coral Gables Florida 33146 —
Boulevard Comprehensive Care Ctr Jacksonville Florida 32209 —
Larry Marc Bush / c/o Sally Yantis Lake Worth Florida 33463 —
Univ of Miami School of Medicine Miami Florida 33136 —
Ctr for Quality Care Tampa Florida 33609 —
Daniel Seekins Tampa Florida 33614 —
Infectious Disease Research Institute Tampa Florida 33614 —
Treasure Coast Infectious Disease Consultants Vero Beach Florida 32960 —
Georgia Research Associates Atlanta Georgia 30342 —
Med College of Georgia Augusta Georgia 30912 —
Infectious Diseases Indianapolis Indiana 46202 —
Univ of Kentucky Med Ctr Lexington Kentucky 40536 —
Kansas City AIDS Research Consortium Kansas City Missouri 64111 —
Univ of Nebraska Med Ctr / HIV Clinic Omaha Nebraska 681985400 —
Univ Med Ctr / HIV Wellness Ctr Las Vegas Nevada 89102 —
Community Research Initiative on AIDS New York New York 10001 —
Clinical Directors Network / HIV/AIDS Program Manager New York New York 10011 —
Wake Forest Univ School of Medicine Winston-Salem North Carolina 27157 —
Remington-Davis Inc Columbus Ohio 43215 —
Philadelphia FIGHT Philadelphia Pennsylvania 19107 —
The Miriam Hosp Providence Rhode Island 02906 —
Research Services 2000 Inc Dallas Texas 75208 —
Division of Infectious Disease / Dept of Internal Medicine Dallas Texas 752359113 —
Research Services 2000 Inc Fort Worth Texas 76103 —
Montrose Clinic Houston Texas 77006 —
UT-Health Science Ctr Houston Texas 77030 —
Diagnostic Clinic of San Antonio San Antonio Texas 78229 —
Oyster Point Med Specialists Newport News Virginia 23606 —
Novum Inc / Pharmaceutical Research Services Seattle Washington 98122 —
Infectious Diseases Associates Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002410, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002410 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →